MRI Screens Women With Familial Breast Cancer

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 5
Volume 9
Issue 5

CHICAGO-In a screening program for young women with a high susceptibility for developing breast cancer, magnetic resonance imaging (MRI) proved more effective than mammography or ultrasound in detecting cancers, German researchers reported at the 85th Annual Meeting of the Radiological Society of North America (RSNA).

 CHICAGO—In a screening program for young women with a high susceptibility for developing breast cancer, magnetic resonance imaging (MRI) proved more effective than mammography or ultrasound in detecting cancers, German researchers reported at the 85th Annual Meeting of the Radiological Society of North America (RSNA).

The Screening Program

In 1996, researchers at the University of Bonn began a multicenter trial on the identification and care of women who carry gene mutations associated with breast cancer or who have a strong personal or family history of breast cancer.

These women were entered into a screening program that consists of a clinical visit and ultrasound twice a year, and two-view mammography and MRI once a year.

Of 262 women in the study, 105 have undergone the full screening protocol and been followed for 3 years. Fifteen have been diagnosed with breast cancer, nine asymptomatic and six symptomatic.

Christiane K. Kuhl, MD, reported that breast MRI was the only imaging modality to detect and correctly classify cancer in all nine of the asymptomatic women and all six of the symptomatic patients. Mammography and ultrasound combined detected cancer in only four of the nine asymptomatic women and four of six symptomatic individuals.

Breast MRI also produced fewer false-positive findings than mammography or ultrasound. Mammography had 7 false-positive biopsy calls, ultrasound had 19, and MRI had 5.

MRI maintained a consistent positive predictive value and high specificity (see Table) despite a high prevalence of patients with MRI contrast enhancement that was classified as insignificant, benign, or cyclical-phase induced (52%).

“In these high-risk women, MRI is able to identify breast cancer that is occult on both mammography and ultrasound,” Dr. Kuhl said.

Recent Videos
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content